Predictors of left ventricular remodelling in kidney transplant recipents in the first posttransplant year

Bosnian Journal of Basic Medical Sciences

Volumn 10, Issue SUPPL. 1, 2010, Pages

  Džemidžić, Jasminka ^a   Rašić, Senija ^a   Saracević, Adnan ^a   Rebić, Damir ^a   Uncanin, Snežana ^a   Srna, Amira ^a   Muslimović, Alma ^a  

^a UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

Author keywords

Echocardiography; Kidney transplantation; Left ventricular remodelling

Indexed keywords

ADULT; ANEMIA; BLOOD PRESSURE; COMPLICATION; ECHOCARDIOGRAPHY; FEMALE; HEART VENTRICLE REMODELING; HUMAN; HYPERPARATHYROIDISM; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PHYSIOLOGY; PROCEDURES; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME;

ADULT; ANEMIA; BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERPARATHYROIDISM; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR REMODELING;

EID: 77953236000     PISSN: 15128601     EISSN: None     Source Type: Journal    
DOI: 10.17305/bjbms.2010.2649     Document Type: Article

References (15)

1. Sarnak M. J., Levey A. S., Schoolwerth A. C. et al. Kidney disease as a risk factor for development of cardiovascular disease. Circulation 2003;108:2154-2169.
2. Hernandez D. Left ventricular hypertrophy after renal transplantation: new approach to a deadly disorder Nephrol. Dial Transplant 2004;19:1682-1686.
3. Baigent C., Landray M. Which cardiovascular risk factors matter in chronic kidney disease. Nephol Dial. Trans. 2007;22:9-11.
4. Dimeny E. M. Cardiovascular disease after renal transplantation. Kidney Int. 2002;61:78-84.
5. Mark P. B., Patel R. K., Jardine A. G. Are we overestimating left ventricular abnormalities in end stage renal disease? Nephrol. Dial Transplant. 2007;22:1815-1819.
6. London G. M. Cardiovascular disease in chronic renal failure, patophysiological aspect. Emm. Dial. 2003;16(2):85-94.
7. Weiner D. E., Sarnak M. J. Chronic Kidney Disease and Cardiovascular Disease: A Bi-Directional Relationship? Dial. Transplant. 2007;36(3):113-118.
8. Callaghan C. J., Bradley J. A. Current status of renal transplantation. Methods Mol Biol. 2006;333:1-28.
9. Rašić S., Kulenović I., Haračić A., Ćatović A. Left ventricular hypertrophy and risk factors for its development in uraemic patients. Bosn. J. Basic Med. Sci. 2004;4(1):34-40.
10. Parashur A. The 2006 K/DOQI Anaemia Guidelines for CKD: Key Updates. Dialysis et Transplantation 2006;35:632-634
11. Levin A. The relationship of haemoglobin level and survival direct or indirect effects? Nephrol. Dial. Transplant. 2001;16(Suppl 2) 7-11.
12. Amann K., Wiest G., Klaus G., Ritz E., Mall G. The role of parathyroid hormone in the genesis of interstitial cell activation in uraemia. J. Am. Soc. Nephrol. 1994;4:1814-1819.
13. Lasic B. L., DeVita M. V., Michelis M. F. Coronary artery calcifications and bone pathology in haemodialysis patients with lower PTH levels. Dial. Transplant. 2005;34(12):845-850.
14. Gill J. S., Tonelli M., Mix C. H., Pereira B. J. The changes in allograft function among long-term kidney transplant recipients. J. Am. Soc. Nephrol 2003;14:136-142.
15. Moreso F., Grinyp J. M. Graft dysfunction and cardiovascular riskan unholy alliance. Nephrol. Dial. Transplant. 2007;22:699-702.